Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yixing Jiang

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Gastrointestinal Cancer Research : GCR|March 5, 2009
Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisitedEdward H Lin, Yixing Jiang, Yanhong Deng, et al.
Cancer|June 16, 2009
Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancerYixing Jiang, Eric T Kimchi, Kevin F Staveley-O'Carroll, et al.
Gastrointestinal Cancer Research : GCR|November 2, 2011
Refining docetaxel-containing therapy for gastric cancerNushmia Z Khokhar, Yixing Jiang, Al B Benson, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
What is the role of maintenance therapy in the treatment of non-small cell lung cancer?Yixing Jiang, Taofeek K Owonikoko, Suresh S Ramalingam, et al.
Expert Review of Anticancer Therapy|June 7, 2008
Upper gastrointestinal tumors: current status and future perspectivesYixing Jiang, Eric T Kimchi, Alberto J Montero, et al.
Gastrointestinal Cancer Research : GCR|March 5, 2009
Optimizing imatinib mesylate treatment in gastrointestinal stromal tumorsYixing Jiang, Lee Ming, Alberto J Montero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancerWeida Gong, Yixing Jiang, Liwei Wang, et al.
Cancers|May 13, 2023
Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related MalignanciesJonathan Charles, Andrea Vrionis, Arian Mansur, et al.
Cancer Chemotherapy and Pharmacology|September 22, 2023
A phase I study of the ceramide nanoliposome in patients with advanced solid tumorsAaron Ciner, Theodore Gourdin, Jeff Davidson, et al.
Current Clinical Pharmacology|November 10, 2015
Advances in the Pharmacologic Treatment of Hepatocellular CarcinomaNeil H Bhayani, Yixing Jiang, Osama Hamed, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Gastrointestinal Cancer Research : GCR|March 5, 2009
Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisitedEdward H Lin, Yixing Jiang, Yanhong Deng, et al.
Cancer|June 16, 2009
Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancerYixing Jiang, Eric T Kimchi, Kevin F Staveley-O'Carroll, et al.
Gastrointestinal Cancer Research : GCR|November 2, 2011
Refining docetaxel-containing therapy for gastric cancerNushmia Z Khokhar, Yixing Jiang, Al B Benson, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
What is the role of maintenance therapy in the treatment of non-small cell lung cancer?Yixing Jiang, Taofeek K Owonikoko, Suresh S Ramalingam, et al.
Expert Review of Anticancer Therapy|June 7, 2008
Upper gastrointestinal tumors: current status and future perspectivesYixing Jiang, Eric T Kimchi, Alberto J Montero, et al.
Gastrointestinal Cancer Research : GCR|March 5, 2009
Optimizing imatinib mesylate treatment in gastrointestinal stromal tumorsYixing Jiang, Lee Ming, Alberto J Montero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancerWeida Gong, Yixing Jiang, Liwei Wang, et al.
Cancers|May 13, 2023
Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related MalignanciesJonathan Charles, Andrea Vrionis, Arian Mansur, et al.
Cancer Chemotherapy and Pharmacology|September 22, 2023
A phase I study of the ceramide nanoliposome in patients with advanced solid tumorsAaron Ciner, Theodore Gourdin, Jeff Davidson, et al.
Current Clinical Pharmacology|November 10, 2015
Advances in the Pharmacologic Treatment of Hepatocellular CarcinomaNeil H Bhayani, Yixing Jiang, Osama Hamed, et al.
Pageof 7